MichaelScottRutenbergMDPhD

Gastrointestinal Cancer, Sarcoma

Senior Associate Consultant, Radiation Oncology, Mayo Clinic Florida

Dr. Rutenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4500 San Pablo Road South
Jacksonville, FL 32224
Phone+1 904-953-2000

PubMed

76 citations
Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Comp...
Julie A. Bradley, Roi Dagan, Meng Wei Ho, Michael S. Rutenberg, Christopher G. Morris
International Journal of Radiation Oncology, Biology, Physics. 2016-05-01
33 citations
Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer
Xiaoying Liang, Julie A. Bradley, Dandan Zheng, Michael S. Rutenberg, Daniel Yeung
Radiation Oncology. 2018-04-19
15 citations
Proton beam radiotherapy for pancreas cancer
Michael S. Rutenberg, Romaine C. Nichols
Journal of Gastrointestinal Oncology. 2020-02-01

Journal Articles

Prognostic Factors of Radiation Dermatitis Following Passive-Scattering Proton Therapy for Breast Cancer
Nancy Mendenhall, Julie A Bradley, Daniel Yeung, Michael Rutenberg, BioMed Central

$Preoperative Hypofractionated Radiotherapy with FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHOX)$
Preoperative Hypofractionated Radiotherapy with FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHOX)October 13th, 2023